Target Name: STMN4
NCBI ID: G81551
Review Report on STMN4 Target / Biomarker Content of Review Report on STMN4 Target / Biomarker
STMN4
Other Name(s): MGC111012 | Stathmin 4, transcript variant 1 | STMN4_HUMAN | Stathmin-4 | Stathmin-like protein B3 | stathmin-like 4 | RB3 | stathmin 4 | stathmin-like protein B3 | stathmin-like-protein RB3 | STMN4 variant 1 | Stathmin-4 (isoform 1) | Stathmin-like-protein RB3

Understanding STMN4: A Protein Focused on Neurological Disorders

STMN4 (MGC111012) is a protein that is expressed in the brain and is known for its role in the structure and function of the nervous system. STMN4 has been shown to play a key role in the development and progression of a number of neurological disorders, including Alzheimer's disease, Parkinson's disease, and Huntington's disease. As a result, STMN4 has become a focus of interest for researchers studying these conditions and for developing new treatments.

One way that researchers are studying STMN4 is to use it as a drug target. This means studying the effects of drugs on STMN4 and how those effects might be related to the symptoms and conditions associated with these disorders. Researchers are also trying to understand how STMN4 interacts with other proteins in the brain to contribute to the development and progression of these conditions.

Another way that researchers are studying STMN4 is to use it as a biomarker. This means using STMN4 as a protein that can be measured and detected in the brain, blood, or other body fluids to indicate the presence or absence of certain conditions. For example, researchers might use STMN4 as a biomarker to diagnose Alzheimer's disease, or to track the effectiveness of new treatments.

In addition to its potential as a drug target and biomarker, STMN4 is also of interest to researchers because of its structure and function. The protein is composed of four domains: an N-terminus, a transmembrane region, a cytoplasmic tail, and a C-terminus. The N-terminus is the region at the end of the protein that is involved in interactions with other proteins, while the C-terminus is the region at the beginning that is involved in interactions with the cell membrane.

The transmembrane region is the region that lies between the N-terminus and the C-terminus and is responsible for controlling the movement of STMN4 into the cell. This region has been shown to contain a number of different signaling pathways that are involved in the regulation of brain function.

Research has also shown that STMN4 is involved in the formation of the endosomal system, a system that is responsible for the delivery of damaged or dysfunctional proteins to the cell's recycling center. This suggests that STMN4 may be involved in the regulation of protein homeostasis, which is important for maintaining the health and function of the brain.

In conclusion, STMN4 is a protein that is of interest to researchers because of its role in the development and progression of neurological disorders, its involvement in the regulation of brain function, and its potential as a drug target or biomarker. Further research is needed to fully understand the functions of STMN4 and its potential as a therapeutic agent.

Protein Name: Stathmin 4

Functions: Exhibits microtubule-destabilizing activity

The "STMN4 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about STMN4 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

STMND1 | STMP1 | STN1 | STOM | STOML1 | STOML2 | STOML3 | STON1 | STON1-GTF2A1L | STON2 | Store-operating calcium channel channels | STOX1 | STOX2 | STPG1 | STPG2 | STPG3 | STPG3-AS1 | STPG4 | STRA6 | STRA6LP | STRA8 | STRADA | STRADB | STRAP | STRBP | STRC | STRCP1 | STRIP1 | STRIP2 | STRIT1 | STRN | STRN3 | STRN4 | STS | STT3A | STT3A-AS1 | STT3B | STUB1 | STUM | STX10 | STX11 | STX12 | STX16 | STX16-NPEPL1 | STX17 | STX17-DT | STX18 | STX18-AS1 | STX18-IT1 | STX19 | STX1A | STX1B | STX2 | STX3 | STX4 | STX5 | STX5-DT | STX6 | STX7 | STX8 | STXBP1 | STXBP2 | STXBP3 | STXBP4 | STXBP5 | STXBP5-AS1 | STXBP5L | STXBP6 | STYK1 | STYX | STYXL1 | STYXL2 | SUB1 | SUB1P1 | Succinate Dehydrogenase Complex | Succinate-CoA ligase (ADP-forming) | SUCLA2 | SUCLG1 | SUCLG2 | SUCLG2-DT | SUCLG2P2 | SUCNR1 | SUCO | SUDS3 | SUFU | SUGCT | SUGP1 | SUGP2 | SUGT1 | SUGT1P1 | SUGT1P2 | SUGT1P3 | SUGT1P4-STRA6LP-CCDC180 | SULF1 | SULF2 | Sulfotransferase | SULT1A1 | SULT1A2 | SULT1A3 | SULT1A4